AIDS Clinical Trial Group
The Division contributes about 40 percent of the effort of the collaborative, NIH-funded Harvard/Boston Medical Center AIDS Clinical Trials Group (ACTG). This collaborative conducts clinical trials evaluating antiretroviral therapy as well as therapy and prophylaxis of AIDS-related opportunistic infections. The collaborative also develops laboratory technologies and standards to support these trials. The AIDS clinical research activities of the Division operate from the Infectious Disease Clinic and, to a lesser degree, the Harvard-Thorndike GCRC. Dr. Mary Albrecht (the institutional Principal Investigator) leads this effort with support from Drs. Bruce Dezube, Lori Panther, and 1 research nurse. This group also conducts industry-funded AIDS related clinical trials.
Drs. John Doweiko and Bruce Dezube (Hematology-Oncology Division) coordinate trials of treatment for AIDS-related malignancies.
Dr. Lori Panther has initiated a clinical and research oriented Anal Screening Clinic to investigate and treat human papilloma virus (HPV) infection, anal warts, and HPV induced anal cancer.
